{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:38:23Z","timestamp":1769114303445,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejim.2020.06.022","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T17:53:22Z","timestamp":1593539602000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Systemic sclerosis is an independent risk factor for ischemic heart disease, especially in patients carrying certain antiphospholipid antibodies: A large cross-sectional study"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-8027","authenticated-orcid":false,"given":"Abdulla","family":"Watad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola L.","family":"Bragazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2390-6505","authenticated-orcid":false,"given":"Giovanni","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Comaneshter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merav","family":"Lidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejim.2020.06.022_bib0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2020.06.022_bib0002","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.ejim.2020.06.022_bib0003","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2105\/AJPH.90.9.1463","article-title":"Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States","volume":"90","author":"Walsh","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ejim.2020.06.022_bib0004","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/j.ejim.2013.08.289","article-title":"Mortality prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit","volume":"24","author":"Doti","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.ejim.2020.06.022_bib0005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/ard.60.5.433","article-title":"Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies","volume":"60","author":"Abu-Shakra","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ejim.2020.06.022_bib0006","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.ATV.0000174800.78362.ec","article-title":"Atherosclerosis in patients with autoimmune disorders","volume":"25","author":"Frostegard","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ejim.2020.06.022_bib0007","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12026-016-8884-9","article-title":"Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study","volume":"65","author":"Watad","year":"2017","journal-title":"Immunol Res"},{"issue":"4","key":"10.1016\/j.ejim.2020.06.022_bib0008","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.autrev.2016.01.006","article-title":"Coexistence of ischemic heart disease and rheumatoid arthritis patients-a case control study","volume":"15","author":"Houri Levi","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.ejim.2020.06.022_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1741-7015-12-47","article-title":"Is atherosclerosis an autoimmune disease?","volume":"12","author":"Matsuura","year":"2014","journal-title":"BMC Med"},{"issue":"21","key":"10.1016\/j.ejim.2020.06.022_bib0010","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ejim.2020.06.022_bib0011","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.06.022_bib0012","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ejim.2020.06.022_bib0013","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ejim.2020.06.022_bib0014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/acr.22152","article-title":"Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis","volume":"66","author":"Dave","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.ejim.2020.06.022_bib0015","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4330\/wjc.v6.i9.993","article-title":"Cardiac manifestations in systemic sclerosis","volume":"6","author":"Lambova","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.ejim.2020.06.022_bib0016","doi-asserted-by":"crossref","unstructured":"Watad A, Tiosano S, Grysman N, Comaneshter D, Cohen AD, Shoenfeld Y, et\u00a0al. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysisEur J Clin Invest. 2017;47(5):366-71.","DOI":"10.1111\/eci.12744"},{"issue":"5","key":"10.1016\/j.ejim.2020.06.022_bib0017","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.autrev.2016.01.019","article-title":"Hypothyroidism among SLE patients: case\u2013control study","volume":"15","author":"Watad","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.ejim.2020.06.022_bib0018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejim.2020.06.022_bib0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2017.02.135","article-title":"Investigating the link between ischemic heart disease and Behcet's disease: a cross-sectional analysis","volume":"241","author":"Yavne","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2020.06.022_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.rdc.2007.12.002","article-title":"The heart in scleroderma","volume":"34","author":"Champion","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"issue":"7","key":"10.1016\/j.ejim.2020.06.022_bib0021","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2012-202007","article-title":"The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study","volume":"72","author":"Man","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ejim.2020.06.022_bib0022","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1136\/annrheumdis-2011-201176","article-title":"Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis","volume":"71","author":"Ngian","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ejim.2020.06.022_bib0023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.59.1.39","article-title":"Macrovascular disease and systemic sclerosis","volume":"59","author":"Ho","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ejim.2020.06.022_bib0024","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/MOL.0b013e32834aa0c2","article-title":"The autoimmune concept of atherosclerosis","volume":"22","author":"Grundtman","year":"2011","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"10.1016\/j.ejim.2020.06.022_bib0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI200111380","article-title":"Lymphocytes are important in early atherosclerosis","volume":"108","author":"Song","year":"2001","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ejim.2020.06.022_bib0026","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1084\/jem.20100155","article-title":"B cell depletion reduces the development of atherosclerosis in mice","volume":"207","author":"Ait-Oufella","year":"2010","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ejim.2020.06.022_bib0027","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar2408","article-title":"Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors","volume":"10","author":"Hettema","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.ejim.2020.06.022_bib0028","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/rheumatology\/ken078","article-title":"Macrovascular disease and atherosclerosis in SSc","volume":"47","author":"Kallenberg","year":"2008","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.ejim.2020.06.022_bib0029","first-page":"412","article-title":"Circulating levels of N\u025b-(carboxymethyl)lysine are increased in systemic sclerosis","volume":"46","author":"Del Rosso","year":"2006","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.ejim.2020.06.022_bib0030","first-page":"199","article-title":"Systemic sclerosis is not associated with clinical or ambulatory blood pressure","volume":"21","author":"Zakopoulos","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.ejim.2020.06.022_bib0031","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ejim.2020.06.022_bib0032","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ejim.2020.06.022_bib0033","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.semarthrit.2016.10.004","article-title":"Clinical relevance of antiphospholipid antibodies in systemic sclerosis: a systematic review and meta-analysis","volume":"46","author":"Merashli","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2020.06.022_bib0034","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.3389\/fimmu.2018.02457","article-title":"Prevalence and clinical associations of antiphospholipid antibodies in systemic sclerosis: new data from a french cross-sectional study, systematic review, and meta-analysis","volume":"9","author":"Sobanski","year":"2018","journal-title":"Front Immunol"},{"issue":"6 Pt 1","key":"10.1016\/j.ejim.2020.06.022_bib0035","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0002-8703(98)70060-2","article-title":"Diversity of myocardial involvement in systemic sclerosis: an 8-year study of 95 Japanese patients","volume":"135","author":"Murata","year":"1998","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ejim.2020.06.022_bib0036","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/art.24684","article-title":"Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients","volume":"60","author":"Boin","year":"2009","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.ejim.2020.06.022_bib0037","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1191\/0961203304lu1011oa","article-title":"Antiphospholipid antibodies in acute coronary syndrome","volume":"13","author":"Veres","year":"2004","journal-title":"Lupus"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520302685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520302685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:32:54Z","timestamp":1760607174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620520302685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":37,"alternative-id":["S0953620520302685"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.06.022","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic sclerosis is an independent risk factor for ischemic heart disease, especially in patients carrying certain antiphospholipid antibodies: A large cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}